ASPARTAME
ASPARTAME
LIST OF FIGURES............................................................................................................... ii
LIST OF TABLE ................................................................................................................... ii
I. OVERVIEW OF ASPARTAME ..................................................................................... 1
1.1. CONCEPT AND HISTORY OF DEVELOPMENT ................................................ 1
1.1.1 What is Aspartame? ........................................................................................ 1
1.1.2 History of development and use ...................................................................... 1
1.2 CHEMICAL STRUCTURE AND PROPERTIES .................................................... 2
1.2.1 Molecular Structure ............................................................................................. 2
1.2.2 Aspartame Metabolism ........................................................................................ 3
1.2.3 Sweetness ........................................................................................................ 4
II. PURPOSE OF ASPARTAME UTILIZATION IN THE FOOD INDUSTRY ....... 5
2.1. Demand for Sweeteners in the Food Industry ....................................................... 5
2.2 Primary Objectives of Aspartame Utilization ........................................................ 6
III. PRODUCT GROUP USING ASPARTAMINE......................................................... 6
3.1 Beverage................................................................................................................. 6
3.2 Confectionery (Sweets & Desserts) ..................................................................... 11
3.3 Dairy & Dairy-like Products .................................................................................... 14
REFERENCE ........................................................................................................................18
i
LIST OF FIGURES
Figure 1. Molecular structure of aspartame ................................................................... 3
Figure 2. Selected beverage products formulated with aspartame............................... 7
Figure 3. Phenylalanine warning label on products containing aspartame ................. 8
Figure 4. Production process of soft drinks formulated with aspartame and
acesulfame potassium ........................................................................................................ 9
Figure 5. Production process of reduced sugar desserts .............................................. 12
Figure 6. Production process of sugar-free chewing gum ........................................... 13
LIST OF TABLE
Table 1. General description of aspartame (Budavari et al., 1999; Sweetman, 2002;
FCC, 2003; Burdock, 2005) .............................................................................................. 3
Table 2. Products of aspartame metabolism. .................................................................. 4
Table 3. Comparison of Sweetness Among Sweetening Additives ................................ 5
Table 4. Application levels of aspartame in selected food categories ......................... 10
Table 5. Acceptable Daily Intake (ADI) for Aspartame .............................................. 13
Table 6. Aspartame Levels in Sugar Free Products ..................................................... 14
Table 7. Regulatory Limits for Aspartame: ADI and Maximum Permitted Levels . 17
ii
I. OVERVIEW OF ASPARTAME
1.1. CONCEPT AND HISTORY OF DEVELOPMENT
1.1.1 What is Aspartame?
Aspartame [L-aspartyl-L-phenylalanine methyl ester] is a dipeptide composed primarily
of two amino acids, phenylalanine, and aspartic acid. These, and other amino acids, are
natural constituents of protein-containing foods consumed in any healthful diet. When
phenylalanine and aspartic acid are combined in a certain way to form aspartame, they
produce an intensely sweet-tasting substance.
During World War II, agricultural crises caused severe reductions in sugar production,
resulting in limited availability of sucrose that could not satisfy consumer demand. Under
these circumstances, artificial sweeteners (ASWs), also known as nonnutritive sweeteners
(NNSs), gained widespread acceptance as partial substitutes for sucrose in food and
beverage formulations.
Saccharin rapidly emerged as the first widely used noncaloric sweetener and became
popularly known as the “poor man’s sugar” during this period, when natural sugar was
scarce and expensive. As the earliest sugar substitute, saccharin has also been the most
extensively studied sweetener to date. However, despite its high sweetening intensity,
saccharin exhibits a characteristic bitter aftertaste, which gradually reduced consumer
acceptance and created increasing demand for novel sweeteners with improved sensory
quality, particularly with respect to taste profile (Sawant, 2011).
In 1937, fifty nine years after the discovery of saccharin, Michael Sveda, a graduate
student at the University of Illinois, accidentally discovered another sweetener,
cyclamate. At that time, Sveda was conducting research on antipyretic drugs in
Audrieth’s laboratory when he unconsciously placed his cigarette on the laboratory
bench. When he later put the cigarette back into his mouth, he noticed an unexpected
1
sweet taste. This observation led to the identification of a new compound, later known as
cyclamate, with potential application as a sugar substitute (Sawant, 2011).
Aspartame is the third major artificial sweetener, was commercially introduced in 1981.
Similar to saccharin and cyclamate, its discovery was a product of chance. According to
historical accounts, James M. Schlatter, a chemist at G.D. Searle, was synthesizing a
tetrapeptide, a compound consisting of four amino acids, as part of a research program
for treating gastric ulcers. During the synthesis process, a small quantity of a dipeptide
intermediate, L aspartyl L phenylalanine methyl ester, unintentionally came into contact
with his hands. When he later licked his finger before handling paperwork, he perceived
an intense sweet taste.
Initially attributing the sweetness to residual food, Schlatter subsequently realized that he
had washed his hands after eating. Consequently, similar to the earlier discoveries of
saccharin and cyclamate, he traced the source of sweetness back to the laboratory
compound. Given that aspartic acid and phenylalanine are naturally occurring amino
acids present in dietary proteins, he further evaluated the compound organoleptically and
confirmed its pronounced sweetness, notably without the bitter aftertaste associated with
saccharin.
It has also been reported that Schlatter and his laboratory colleague, Harman Lowrie,
tested the compound in 10 mL of black coffee to assess its sensory performance in a
beverage matrix. Their supervisor, Robert J. Mazur, subsequently recognized its
commercial potential and advocated for its development as a widely distributed high
intensity artificial sweetener for food and beverage applications.
2
Figure 1. Molecular structure of aspartame
Table 1. General description of aspartame (Budavari et al., 1999; Sweetman, 2002;
FCC, 2003; Burdock, 2005)
3
Methanol is firstly oxidized in the liver to formaldehyde and again to formic acid;
however, while methanol is known to damage the liver, formaldehyde and formate are
also responsible for the destruction of liver cells. In addition, during the process the
formation of superoxide anions and hydrogen peroxide occur, which lead to protein
denaturation and subsequent enzymatic changes ( Trocho et al., 1998; Skrzydlewska et
al., 2000; Ashok et al., 2015) . According to the study on the impact of aspartame
administration on trans-sulfuration pathway, decrease of most metabolites of the trans-
sulphuration pathway in the liver was observed during experiment. Levels of cysteine,
homocysteine, S-adenosyl-homocysteine, and S-adenosyl-methionine were increased.
There was no significant change in methionine and cystathionine level ( Finamor et al.,
2017). All mentioned aspartame metabolites are toxic to the brain. Furthermore,
rhenylalanine is mainly metabolized to tyrosine and smaller amounts of
phenylethylamine and phenylpyruvate, while aspartic acid is metabolized into alanine
and oxaloacetate. It has been suggested that in human beings consuming large amounts,
aspartame may be a significant source of formate, which can contribute to serious
physiological changes. The role of aspartame in several disorders affecting human body
remains to be investigated. Most importantly, people with phenylketonuria, a genetic
disorder in which patients cannot convert phenylalanine to tyrosine, must avoid
aspartame. Due to the harmful effects of aspartame on phenylketonuria patients,
according to the FDA requirements all products containing aspartame must have a label
informing about the presence of phenylalanine ( Fitch & Keim, 2012).
1.2.3 Sweetness
Aspartame is a high intensity sweetener that is widely used in the food industry, with a
relative sweetness approximately 180 to 200 times greater than that of sucrose. The
perceived sweetness of aspartame is not constant and is influenced by several factors,
including usage concentration, temperature, environmental pH, and the nature of the food
matrix. Compared with saccharin, aspartame exhibits significantly less bitter aftertaste,
resulting in improved sensory acceptance in food and beverage applications.
4
Table 3. Comparison of Sweetness Among Sweetening Additives
In recent decades, the global food industry has experienced a significant shift in
consumer trends toward health oriented products. The increasing prevalence of
noncommunicable diseases such as obesity, type 2 diabetes mellitus, and metabolic
syndrome has intensified the demand for reduced intake of free sugars in the daily diet.
International health organizations recommend limiting added sugar consumption in order
to decrease the risk of metabolic disorders and cardiovascular complications. Within this
context, reducing sucrose content in foods and beverages has become a major objective
for food manufacturers.
However, sugar serves not only as a sweetening agent but also plays a critical role in
determining product structure, texture, mouthfeel, and overall sensory acceptability.
Therefore, complete removal of sugar without compromising product quality presents a
significant technological challenge. For this reason, high intensity sweeteners have been
extensively researched and applied to partially or totally replace conventional sugars.
Among these, aspartame is considered one of the most widely used options due to its
sweetness profile, which closely resembles that of sucrose, combined with its low caloric
contribution.
In addition to health considerations, market competition and the need for product
diversification have accelerated the development of low calorie, diet, and sugar free
5
product lines. The incorporation of aspartame enables manufacturers to maintain
desirable sensory characteristics while substantially reducing sugar content and overall
energy value. This approach allows producers to simultaneously meet nutritional
objectives, economic efficiency, and evolving consumer preferences.
It's a dry base for certain foods, like instant coffee and tea, gelatins, puddings, fillings,
and dairy products and toppings. It is not generally found in baked goods because it loses
its sweetness once heated. Aspartame is also found in about 600 pharmaceutical products.
Aspartame E951 is a high intensity sweetener widely applied in the beverage industry,
particularly in low energy and sugar free formulations. Chemically, aspartame is the
methyl ester of a dipeptide composed of L aspartic acid and L phenylalanine. In beverage
manufacturing, aspartame is extensively utilized as a high intensity sweetener to reduce
6
the sugar and caloric content of products while maintaining a sweetness profile closely
resembling that of sucrose. With a relative sweetness approximately 200 to 300 times that
of sucrose, aspartame is incorporated into a variety of beverage categories, including
energy drinks, fruit based beverages, low calorie powdered drink mixes, and sugar free
carbonated soft drinks such as Diet Coke and Pepsi Zero Sugar. Beyond its primary
sweetening function, aspartame exhibits synergistic effects when combined with other
sweeteners and flavoring agents, including acesulfame potassium, saccharin, cyclamate,
and malic acid (BeMiller, 2019). These interactions enhance sweetness intensity, improve
temporal sweetness profile, and prolong fruity flavor perception, thereby supporting
sensory optimization in sugar reduction strategies for beverage formulations.
From a technological perspective, the most critical factors affecting the performance of
aspartame are pH and temperature. Aspartame exhibits optimal stability under acidic
conditions, typically within a pH range of 3 to 5, which is compatible with most food and
beverage systems. However, in products such as soft drinks, acid-catalyzed hydrolysis
7
over time removes the methyl ester group, leading to loss of sweetness. In addition,
aspartame is heat sensitive. Prolonged thermal treatment or high temperature sterilization
may lead to significant degradation. Heating at pH values above 5 promotes the
cyclization of aspartame to form diketopiperazine, a degradation product associated with
reduced sweetness intensity. Nevertheless, aspartame is capable of withstanding UHT
heat-processing regimes commonly applied in dairy beverages and fruit juices, as well as
aseptic processing systems, provided that formulation parameters are appropriately
controlled (BeMiller, 2019). Light exposure may further accelerate degradation reactions;
therefore, packaging selection and storage conditions are critical considerations in the
design of beverages formulated with aspartame. One of the degradation products of
aspartame is phenylalanine. Consequently, beverages containing aspartame are required
to carry appropriate labeling statements for individuals with phenylketonuria.
8
Figure 4. Production process of soft drinks formulated with aspartame and
acesulfame potassium
The use of aspartame in beverages is regulated by major food safety authorities through a
dual framework consisting of product-category maximum levels and Acceptable Daily
Intake (ADI) values. Rather than applying a single universal concentration limit,
9
regulatory systems are structured to ensure technological functionality (sweetness
replacement, stability, sensory quality) while maintaining long-term consumer safety.
10
Source: Codex Alimentarius Commission (1995). General Standard for Food Additives
(CODEX STAN 192-1995). FAO/WHO.
11
Overall, the use of aspartame in both sugar-free chewing gum and sugar-free or reduced-
sugar desserts enables the production of low-calorie foods that meet consumer demand
for healthier alternatives without compromising sensory quality. However, careful control
of processing conditions and dosage levels is required to ensure product stability,
regulatory compliance, and consumer safety.
12
Figure 6. Production process of sugar-free chewing gum
There are no fixed, specific maximum levels of aspartame set for each individual food
category like chewing gum or desserts in many global food additive standards. Instead,
the regulatory approach used by major authorities is based on a total dietary exposure
concept meaning manufacturers must ensure that total consumer intake from all foods
does not exceed the Acceptable Daily Intake (ADI).
Aspartame is approved for use in both sugar-free chewing gum and sugar-free or
reduced-sugar desserts such as gelatin, puddings, and jellies by major food safety
authorities including the U.S. Food and Drug Administration (FDA), the European Food
Safety Authority (EFSA), and the Joint FAO/WHO Expert Committee on Food Additives
(JECFA). Rather than establishing fixed maximum limits for individual food products,
these authorities regulate aspartame based on the concept of Acceptable Daily Intake
13
(ADI), which represents the amount that can be safely consumed daily over a lifetime
without appreciable health risk. The ADI for aspartame is set at 50 mg/kg body weight
per day by the FDA and 40 mg/kg body weight per day by EFSA and JECFA.
Consequently, manufacturers of chewing gum and sugar-free desserts must formulate
their products so that typical consumer intake remains below these limits, taking into
account cumulative exposure from multiple dietary sources. Analytical studies indicate
that sugar-free chewing gum typically contains approximately 1000-1900 mg of
aspartame per kilogram of product, corresponding to about 10-19 mg per standard 10 g
piece of gum. In sugar-free or reduced-sugar desserts, such as gelatin, puddings, and
jellies, aspartame levels are generally within a similar or slightly lower range depending
on formulation and serving size, often resulting in 30-150 mg of aspartame per typical
serving. Under normal consumption patterns, these amounts represent only a small
fraction of the ADI, even for frequent consumers, thereby demonstrating that the use of
aspartame in these product categories is considered safe when properly formulated and
consumed according to intended use.
From a technological perspective, aspartame is not used as a bulk ingredient but rather as
a sweetness modifier due to its very high sweetening power. Because it does not
contribute viscosity, body, or fermentable carbohydrates, it allows manufacturers to
preserve the original texture, protein network, and mouthfeel of yogurt and dairy desserts.
14
Importantly, aspartame does not participate in the fermentation process and therefore
does not serve as a substrate for lactic acid bacteria.
In industrial dairy processing, the use of aspartame is carefully integrated into the
production sequence. Milk is first standardized, homogenized, and pasteurized at high
temperatures to ensure microbial safety. After pasteurization, the milk is cooled and
inoculated with starter cultures, and fermentation proceeds until the desired acidity and
texture are achieved. Aspartame is not added before or during fermentation, because it is
sensitive to heat and may undergo degradation during thermal treatment. In addition,
early addition could result in sweetness loss and unnecessary exposure to acidic
conditions.
In dairy desserts such as yogurt-based creams or fermented milk gels, the same principle
applies: all heat treatments and structure-forming steps are completed before aspartame is
added. This processing strategy ensures optimal sensory quality, minimizes sweetener
degradation, and guarantees consistency between batches. Therefore, the successful use
of aspartame in dairy products depends strongly on precise process control and correct
selection of the addition stage.
15
Figure 7. Production process of yogurt with aspartame addition
The use of aspartame in dairy and dairy-like products, particularly sugar-free or reduced-
sugar yogurt and flavored fermented milk products, is regulated by major food safety
authorities through a combination of product-category limits and Acceptable Daily Intake
(ADI) values. Rather than relying solely on a universal dosage level, regulatory
frameworks are designed to ensure both technological suitability and long-term consumer
safety.
At the international level, the Joint FAO/WHO Expert Committee on Food Additives
(JECFA) and the European Food Safety Authority (EFSA) have established an
Acceptable Daily Intake for aspartame of 40 mg per kilogram of body weight per day,
while the U.S. Food and Drug Administration (FDA) has set a slightly higher ADI of 50
mg/kg body weight per day. These ADI values represent the amount of aspartame that
can be consumed daily over an entire lifetime without appreciable health risk and apply
cumulatively across all dietary sources.
16
In addition to ADI-based regulation, the European Union specifies maximum permitted
levels (MPLs) for aspartame in certain food categories. For flavoured fermented milk
products, including yogurt and heat-treated dairy desserts (Food Category 1.4), aspartame
(E951) is permitted at a maximum level of 1000 mg per liter (or kilogram) of product.
This limit represents a formulation ceiling rather than a recommended use level and
ensures that even high consumers remain below the ADI when realistic dietary patterns
are considered.
Overall, regulatory control of aspartame in dairy and dairy-like products relies on a dual
approach: product-specific maximum levels to guide formulation, and ADI-based risk
assessment to protect consumers from excessive cumulative exposure. When used within
these limits and added at the appropriate processing stage, aspartame is considered safe
and technologically suitable for sugar-free dairy applications.
Table 7. Regulatory Limits for Aspartame: ADI and Maximum Permitted Levels
What it means in
Regulation type Authority
practice
Maximum amount a
person can safely
Acceptable Daily Intake (ADI) EFSA, JECFA
consume per day, based
on body weight
Same concept, slightly
Acceptable Daily Intake (ADI) FDA higher limit used in the
USA
EU (Food Category 1.4 Legal maximum
Maximum permitted level (MPL)
flavoured fermented concentration allowed in
in dairy products
milk products) the product formulation
17
REFERENCE
Arora, S., Shendurse, A. M., Sharma, V., Wadhwa, B. K., & Singh, A. K. (2013).
Assessment of stability of binary sweetener blend (aspartame × acesulfame-K) during
storage in whey lemon beverage. Journal of Food Science and Technology, 50(4), 770–
776.
Choudhary, A. K., & Lee, Y. Y. (2018). The debate over neurotransmitter interaction in
aspartame usage. Journal of Clinical Neuroscience, 56, 7–15.
DuBois, G. E. (2008). Sweetness and Sweeteners: What Is All the Excitement About?.
EFSA ANS Panel. (2013). Scientific opinion on the re-evaluation of aspartame (E 951) as
a food additive. EFSA Journal, 11(12), 3496. [Link]
Finamor, I., Pérez, S., Bressan, C. A., Brenner, C. E., Rius-Pérez, S., Brittes, P. C., …
Pavanato, M. A. (2017). Chronic aspartame intake causes changes in the trans-sulfuration
pathway, glutathione depletion and liver damage in mice. Redox Biology, 11, 701–707.
Fitch, C., & Keim, K. S. (2012). Position of the Academy of Nutrition and Dietetics: Use
of nutritive and nonnutritive sweeteners. Journal of the Academy of Nutrition and
Dietetics, 112(5), 739–758.
Humphries, P., Pretorius, E., & Naude, H. (2008). Direct and indirect cellular effects of
aspartame on the brain. European Journal of Clinical Nutrition, 62(4), 451–462.
Ishak, K. G., Zimmerman, H. J., & Ray, M. B. (1991). Alcoholic liver disease:
Pathologic, pathogenetic and clinical aspects. Alcoholism: Clinical and Experimental
Research, 15(1), 45–66.
18
Kroger, M., Meister, K., & Kava, R. (2006). Low-calorie sweeteners and chewing gum.
Journal of the American Dietetic Association, 106(12), 1871–1877.
Kumari, A., Arora, S., Choudhary, S., Singh, A. K., & Tomar, S. K. (2018). Comparative
stability of aspartame and neotame in yoghurt. International Journal of Dairy
Technology, 71(2), 462–470. [Link]
Kumari, A., Choudhary, S., Arora, S., & Sharma, V. (2016). Stability of aspartame and
neotame in pasteurized and in-bottle sterilized flavoured milk. Food Chemistry, 196,
533–538.
Lachenmeier, D. W., Rehm, J., & Kuballa, T. (2023). Artificial sweeteners in beverages
on the German market: Occurrence and exposure assessment. Nutrients, 15(12), 2774.
Magnuson, B. A., Burdock, G. A., Doull, J., Kroes, R. M., Marsh, G. M., Pariza, M. W.,
Spencer, P. S., Waddell, W. J., Walker, R., & Williams, G. M. (2007). Aspartame: A
safety evaluation based on current use levels, regulations, and toxicological and
epidemiological studies. Critical Reviews in Toxicology, 37(8), 629–727.
[Link]
Miele, N. A., Cabisidan, E. K., Blaiotta, G., Leone, S., Masi, P., Di Monaco, R., &
Cavella, S. (2017). Rheological and sensory performance of a protein-based sweetener
(MNEI), sucrose, and aspartame in yogurt. Journal of Dairy Science, 100(12), 9539–
9550. [Link]
Ranney, R. E., Oppermann, J. A., Muldoon, E., & McMahon, F. G. (1976). Comparative
metabolism of aspartame in experimental animals and humans. Journal of Toxicology
and Environmental Health, 2(2), 441–451.
Skrzydlewska, E., Elas, M., Farbiszewski, R., & Roszkowska, A. (2000). Effect of
methanol intoxication on free-radical induced protein oxidation. Journal of Applied
Toxicology, 20(3), 239–243.
19
Stegink, L. D. (1987). The aspartame story: A model for the clinical testing of a food
additive. The American Journal of Clinical Nutrition, 46(1), 204–215.
Trawiński, J., & Skibiński, R. (2023). Stability of aspartame in soft drinks: Identification
of novel phototransformation products and their toxicity evaluation. Food Research
International, 173, 113365.
Trocho, C., Pardo, R., Rafecas, I., Virgili, J., Remesar, X., Fernandez-Lopez, J. A., &
Alemany, M. (1998). Formaldehyde derived from dietary aspartame binds to tissue
components in vivo. Life sciences, 63(5), 337-349.
20